Serial social-impact entrepreneur creates several potentially investable Pharmacy-related startups.
Co-founders see sector receptive to Cloud-linked technology and sensitive to search and review costs.
Years of work have prepared Meharry researchers to play influential role by drawing data from Nashville General Hospital.
More nondilutive capital for data-oriented lifesciences company.
Startup commercializing VU IP to reduce injury, death and mitigate $50BN annual medical spend.
Transplanted entrepreneur mulls capital and advisors, preps for full market entry
[updated] After sales of specialty pharmacy and other assets to Fred's, Shane Reeves has 100% control.
HealthIT entrepreneur Eric Winter signs-on for another startup rodeo.
VTC Teams arriving for array of Memphis accelerators.
Engineering Dean sees opportunities to address large-scale global needs.
Cole Hawkins, Jade Preis aim to expand from Mid-TN through Southeast
[Updated] Team says rapid Angel-investor enlistment is one reason this is a 'W' for region's LifeSciences
A consolidator has been quietly established in Nashville, focusing on an aging-driven sector.
The local shortage of computer science, other engineering talent oft-cited, while recruiters swarm.
[updated] Prepared for change, EC CEO has already sketched-out 2016 strategy.
Seed to B-round scenario begins to emerge, with pharmacogenetic testing a driver.
Healthbox grad, chronic pain management player pops-up with raise
Co-founder says Seed money seems more likely to come for the Coast.
[updated] This immunization data-collection startup is being accelerated via a university alliance.
[updated] With sector veterans on its board and access to capital, this startup girds for raise.
Two Tennessee-born science-centered companies are united
[updated] Stefansic and Hogin among those departing, with interest in private-sector jobs.
President James Stover says company has good talks with potential strategic partners
TTDC now seems to be fully staffed to further pro-venture programs
A Brailer exec joins regional VC, Nutraceuticals' Grindstaff, Investor Days ahead for incubators, Amazon thing gets awkward and more
Vanderbilt pharma program inches cautiously toward tech transfer, while key faculty member keeps firm hand on the tiller
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: